5 results on '"Toby Lea"'
Search Results
2. Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia.
- Author
-
Toby Lea, Johann Kolstee, Sarah Lambert, Ross Ness, Siobhan Hannan, and Martin Holt
- Subjects
Medicine ,Science - Abstract
Gay and bisexual men (GBM) report higher rates of methamphetamine use compared to heterosexual men, and thus have a heightened risk of developing problems from their use. We examined treatment outcomes among GBM clients receiving outpatient counseling at a lesbian, gay, bisexual, transgender and intersex (LGBTI)-specific, harm reduction treatment service in Sydney, Australia. GBM receiving treatment for methamphetamine use from ACON's Substance Support Service between 2012-15 (n = 101) were interviewed at treatment commencement, and after 4 sessions (n = 60; follow-up 1) and 8 sessions (n = 32; follow-up 2). At each interview, clients completed measures of methamphetamine use and dependence, other substance use, injecting risk practices, psychological distress and quality of life. The median age of participants was 41 years and 56.4% identified as HIV-positive. Participants attended a median of 5 sessions and attended treatment for a median of 112 days. There was a significant reduction in the median days of methamphetamine use in the previous 4 weeks between baseline (4 days), follow-up 1 (2 days) and follow-up 2 (2 days; p = .001). There was a significant reduction in the proportion of participants reporting methamphetamine dependence between baseline (92.1%), follow-up 1 (78.3%) and follow-up 2 (71.9%, p < .001). There were also significant reductions in psychological distress (p < .001), and significant improvements in quality of life (p < .001). Clients showed reductions in methamphetamine use and improved psychosocial functioning over time, demonstrating the potential effectiveness of a LGBTI-specific treatment service.
- Published
- 2017
- Full Text
- View/download PDF
3. Australian gay and bisexual men's attitudes to HIV treatment as prevention in repeated, national surveys, 2011-2013.
- Author
-
Martin Holt, Toby Lea, Dean A Murphy, Jeanne Ellard, Marsha Rosengarten, Susan C Kippax, and John B F De Wit
- Subjects
Medicine ,Science - Abstract
Assess the acceptability of HIV treatment as prevention and early antiretroviral treatment among gay and bisexual men in Australia and any changes in attitudes over time.National, online, cross-sectional surveys of gay and bisexual men were repeated in 2011 and 2013. Changes in attitudes to HIV treatment over time were assessed with multivariate analysis of variance. The characteristics of men who agreed that HIV treatment prevented transmission and thought that early treatment was necessary were identified with multivariate logistic regression.In total, 2599 HIV-negative, untested and HIV-positive men participated (n = 1283 in 2011 and n = 1316 in 2013). Attitudes changed little between 2011 and 2013; most participants remained sceptical about the preventative benefits of HIV treatment. In 2013, only 2.6% of men agreed that HIV treatment prevented transmission; agreement was associated with being HIV-positive, having an HIV-positive regular partner, and having received HIV post-exposure prophylaxis. In contrast, 71.8% agreed that early antiretroviral treatment is necessary; younger men were more likely and HIV-positive men and participants with HIV-positive partners were much less likely to agree with this.Promoting the individual health benefits of HIV treatment rather than its preventative benefits remains more acceptable to Australian gay and bisexual men.
- Published
- 2014
- Full Text
- View/download PDF
4. Characteristics of gay and bisexual men who rarely use HIV risk reduction strategies during condomless anal intercourse: Results from the FLUX national online cohort study
- Author
-
Jeff Jin, Johann Kolstee, Garrett Prestage, Mohamed A. Hammoud, Lisa Maher, Louisa Degenhardt, Martin Holt, and Toby Lea
- Subjects
Male ,Safe Sex ,RNA viruses ,Bisexuals ,Psychological intervention ,Social Sciences ,HIV Infections ,Pathology and Laboratory Medicine ,Logistic regression ,Condoms ,Geographical Locations ,Sexual and Gender Minorities ,Pre-exposure prophylaxis ,0302 clinical medicine ,Immunodeficiency Viruses ,Medicine and Health Sciences ,Psychology ,Medicine ,Homosexuals ,Prospective Studies ,030212 general & internal medicine ,Young adult ,Prospective cohort study ,Multidisciplinary ,Age Factors ,Middle Aged ,Medical Microbiology ,Viral Pathogens ,Viruses ,Educational Status ,Sensory Perception ,Pathogens ,0305 other medical science ,Research Article ,Cohort study ,medicine.drug ,Adult ,Science ,HIV prevention ,Oceania ,Microbiology ,Young Adult ,03 medical and health sciences ,Retroviruses ,Humans ,Microbial Pathogens ,Preventive medicine ,Internet ,030505 public health ,Prophylaxis ,business.industry ,Lentivirus ,Australia ,Organisms ,Biology and Life Sciences ,HIV ,medicine.disease ,Public and occupational health ,Erectile dysfunction ,People and Places ,Pre-Exposure Prophylaxis ,Population Groupings ,business ,Risk Reduction Behavior ,Undergraduates ,Amyl nitrite ,Sexuality Groupings ,Neuroscience ,Demography - Abstract
Purpose To understand the characteristics of a minority of Australian gay and bisexual men (GBM) who, despite an increase in the number and availability of HIV risk reduction strategies, do not consistently use a strategy to protect themselves from HIV. Methods This analysis is based on data from 2,920 participants in a national, online, prospective observational cohort study. GBM who never or rarely used HIV risk reduction strategies (NRR) were compared with two groups using multivariate logistic regression: i) GBM using pre-exposure prophylaxis (PrEP) and ii) GBM frequently using risk reduction strategies (FRR) other than PrEP. Results Compared to PrEP users, NRR men were younger (p
- Published
- 2020
5. Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia
- Author
-
Siobhan Hannan, Sarah Lambert, Toby Lea, Ross Ness, Martin Holt, and Johann Kolstee
- Subjects
Male ,Bisexuals ,030508 substance abuse ,lcsh:Medicine ,Methamphetamine ,0302 clinical medicine ,Quality of life ,Transgender ,Medicine and Health Sciences ,Ambulatory Care ,Homosexuals ,030212 general & internal medicine ,Young adult ,lcsh:Science ,Drug Dependence ,Alcohol Consumption ,Multidisciplinary ,Pharmaceutics ,Middle Aged ,Treatment Outcome ,Behavioral Pharmacology ,Physical Sciences ,Bisexuality ,Female ,Substance Abuse Treatment Centers ,0305 other medical science ,Psychosocial ,Research Article ,medicine.drug ,Adult ,medicine.medical_specialty ,Materials by Structure ,Sexual Behavior ,Materials Science ,Amphetamine-Related Disorders ,Crystals ,Transgender Persons ,Young Adult ,03 medical and health sciences ,Pharmacotherapy ,Drug Therapy ,Ambulatory care ,medicine ,Humans ,Homosexuality, Male ,Psychiatry ,Nutrition ,Pharmacology ,Psychological and Psychosocial Issues ,Harm reduction ,business.industry ,lcsh:R ,Australia ,Biology and Life Sciences ,Diet ,Health Care ,People and Places ,Quality of Life ,Population Groupings ,Central Nervous System Stimulants ,lcsh:Q ,business ,Sexuality Groupings - Abstract
Gay and bisexual men (GBM) report higher rates of methamphetamine use compared to heterosexual men, and thus have a heightened risk of developing problems from their use. We examined treatment outcomes among GBM clients receiving outpatient counseling at a lesbian, gay, bisexual, transgender and intersex (LGBTI)-specific, harm reduction treatment service in Sydney, Australia. GBM receiving treatment for methamphetamine use from ACON’s Substance Support Service between 2012–15 (n = 101) were interviewed at treatment commencement, and after 4 sessions (n = 60; follow-up 1) and 8 sessions (n = 32; follow-up 2). At each interview, clients completed measures of methamphetamine use and dependence, other substance use, injecting risk practices, psychological distress and quality of life. The median age of participants was 41 years and 56.4% identified as HIV-positive. Participants attended a median of 5 sessions and attended treatment for a median of 112 days. There was a significant reduction in the median days of methamphetamine use in the previous 4 weeks between baseline (4 days), follow-up 1 (2 days) and follow-up 2 (2 days; p = .001). There was a significant reduction in the proportion of participants reporting methamphetamine dependence between baseline (92.1%), follow-up 1 (78.3%) and follow-up 2 (71.9%, p < .001). There were also significant reductions in psychological distress (p < .001), and significant improvements in quality of life (p < .001). Clients showed reductions in methamphetamine use and improved psychosocial functioning over time, demonstrating the potential effectiveness of a LGBTI-specific treatment service.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.